technology
Vir Biotechnology priced its initial public offering (IPO) at $20 a share on Thursday, at the bottom end of expectations, a fresh blow for SoftBank Group Corp's Vision Fund, owner of 21% in the infectious disease researcher.
from Reuters: Technology News https://ift.tt/2ovFXQk
via Blogger https://ift.tt/33nhDyV
Next
« Prev Post
« Prev Post
Previous
Next Post »
Next Post »
Subscribe to:
Post Comments (Atom)
EmoticonEmoticon